PIM
XBI icon

Partner Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Partner Investment Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,792
Closed -$904K – 98
2017
Q3 		$934K Buy
+10,792
New +$865K 0.89% 41
2017
Q1 		– Sell
-10,684
Closed -$632K – 118
2016
Q4 		$632K Buy
+10,684
New +$660K 0.84% 39

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Partner Investment Management's XBI Position: Q4 2017 in Review

Partner Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2017, closing a stake of 10,792 shares — an estimated $904K sold.

Partner Investment Management first reported a position in XBI in Q4 2016 and held it in 2 quarters. The position peaked at $934K in Q3 2017. 397 funds tracked by Wall St. Rank hold XBI as of Q4 2017.

  • Partner Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2017 after selling out during the quarter.
  • Partner Investment Management sold 10,792 State Street SPDR S&P Biotech ETF shares in Q4 2017, an estimated $904K.
  • Partner Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 2 quarters.
  • Partner Investment Management's State Street SPDR S&P Biotech ETF position peaked at $934K in Q3 2017.
  • 397 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2017.

Based on Partner Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.